Improved sensitivity of the nano ultra-high performance liquid chromatography-tandem mass spectrometric analysis of low-concentrated neuropeptides by reducing aspecific adsorption and optimizing the injection solvent
“…The ACN and FA proportion in the loading solvent is much more critical compared to its proportion in the injection solvent. Indeed, we have previously shown [31] that the addition of much higher proportions of these solvents, 13.1% V/V ACN and 4.4% V/V FA, to the sample in the UHPLC vial (injection solvent) are needed to improve sensitivity. This contrast strengthens the necessity of optimizing every single step of the analysis.…”
Section: Trap Columnmentioning
confidence: 99%
“…The optimum conditions, solvent compositions and container materials for standard preparation and injection have been previously determined [31] and are applied in this study. Initial stock solutions of NT, NMB and NMN are prepared by dissolving 1 mg of the lyophilized peptide powders in 1 ml of water/ ACN/FA (45/50/5 V/V/V), thus creating standard solutions of 598 μM NT, 883 μM NMB and 1340 μM NMN.…”
Section: Preparation Of Standard Solutionsmentioning
confidence: 99%
“…The solvents applied in our previous study [31] for reducing adsorption of peptides during standard preparation, namely water/FA (95/5 V/V), water/ACN (50/50 V/V), water/ACN/FA (45/50/5 V/V/V), ACN/ FA (95/5 V/V) and ACN are tested as strong wash.…”
Section: Autosamplermentioning
confidence: 99%
“…The dwell time is set at 84 ms. The source and analyzer settings on the Quattro Premier are as previously described [31]. The settings on the XEVO TQ-S instrument are: capillary voltage 4.0 kV; source offset 50 V; source temperature 80°C; extractor voltage 5.00 V; RF lens voltage 0.0 V; entrance and exit voltages of the collision cell 1.0 V. The ion energies are set at 0.5 and 1.0, and the multiplier voltage is 531 V. All measurements on both MS detectors are controlled by MassLynx® version 4.1 operating software (Waters, MA, USA).…”
Section: Msmentioning
confidence: 99%
“…The first challenge has already been extensively investigated in our previous study [31]. Indeed, a significant improvement in sensitivity is observed after reducing aspecific adsorption of peptides during standard preparation (for review, see [32,33]), and by optimizing the injection solvent used for loading the peptides onto the trap column.…”
Aim: An ultrasensitive nano UHPLC–ESI–MS/MS method is developed to simultaneously monitor three low-concentration neuromedin-like peptides in microdialysates. Results: Peptide preconcentration and sample desalting is performed online on a trap column. A shallow gradient slope at 300 nl/min on the analytical column maintained at 35°C, followed by two saw-tooth column wash cycles, results in the highest sensitivity and the lowest carryover. The validated method allows the accurate and precise quantification of 0.5 pM neurotensin and neuromedin N (2.5 amol on column), and of 3.0 pM neuromedin B (15.0 amol on column) in in vivo microdialysates without the use of internal standards. Conclusion: The assay is an important tool for elucidating the role of these neuromedin-like peptides in the pathophysiology of neurological disorders.
“…The ACN and FA proportion in the loading solvent is much more critical compared to its proportion in the injection solvent. Indeed, we have previously shown [31] that the addition of much higher proportions of these solvents, 13.1% V/V ACN and 4.4% V/V FA, to the sample in the UHPLC vial (injection solvent) are needed to improve sensitivity. This contrast strengthens the necessity of optimizing every single step of the analysis.…”
Section: Trap Columnmentioning
confidence: 99%
“…The optimum conditions, solvent compositions and container materials for standard preparation and injection have been previously determined [31] and are applied in this study. Initial stock solutions of NT, NMB and NMN are prepared by dissolving 1 mg of the lyophilized peptide powders in 1 ml of water/ ACN/FA (45/50/5 V/V/V), thus creating standard solutions of 598 μM NT, 883 μM NMB and 1340 μM NMN.…”
Section: Preparation Of Standard Solutionsmentioning
confidence: 99%
“…The solvents applied in our previous study [31] for reducing adsorption of peptides during standard preparation, namely water/FA (95/5 V/V), water/ACN (50/50 V/V), water/ACN/FA (45/50/5 V/V/V), ACN/ FA (95/5 V/V) and ACN are tested as strong wash.…”
Section: Autosamplermentioning
confidence: 99%
“…The dwell time is set at 84 ms. The source and analyzer settings on the Quattro Premier are as previously described [31]. The settings on the XEVO TQ-S instrument are: capillary voltage 4.0 kV; source offset 50 V; source temperature 80°C; extractor voltage 5.00 V; RF lens voltage 0.0 V; entrance and exit voltages of the collision cell 1.0 V. The ion energies are set at 0.5 and 1.0, and the multiplier voltage is 531 V. All measurements on both MS detectors are controlled by MassLynx® version 4.1 operating software (Waters, MA, USA).…”
Section: Msmentioning
confidence: 99%
“…The first challenge has already been extensively investigated in our previous study [31]. Indeed, a significant improvement in sensitivity is observed after reducing aspecific adsorption of peptides during standard preparation (for review, see [32,33]), and by optimizing the injection solvent used for loading the peptides onto the trap column.…”
Aim: An ultrasensitive nano UHPLC–ESI–MS/MS method is developed to simultaneously monitor three low-concentration neuromedin-like peptides in microdialysates. Results: Peptide preconcentration and sample desalting is performed online on a trap column. A shallow gradient slope at 300 nl/min on the analytical column maintained at 35°C, followed by two saw-tooth column wash cycles, results in the highest sensitivity and the lowest carryover. The validated method allows the accurate and precise quantification of 0.5 pM neurotensin and neuromedin N (2.5 amol on column), and of 3.0 pM neuromedin B (15.0 amol on column) in in vivo microdialysates without the use of internal standards. Conclusion: The assay is an important tool for elucidating the role of these neuromedin-like peptides in the pathophysiology of neurological disorders.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.